<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <latestAction>
      <actionDate>2013-03-21</actionDate>
      <text>Referred to the House Committee on Oversight and Government Reform.</text>
      <links />
    </latestAction>
    <committeeReports />
    <cboCostEstimates />
    <billType>HR</billType>
    <relatedBills />
    <createDate>2013-03-22T07:01:12Z</createDate>
    <title>FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act</title>
    <cosponsors>
      <item>
        <lastName>CUMMINGS</lastName>
        <sponsorshipDate>2013-03-21</sponsorshipDate>
        <firstName>ELIJAH</firstName>
        <identifiers>
          <lisID>256</lisID>
          <gpoId>7982</gpoId>
          <bioguideId>C000984</bioguideId>
        </identifiers>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <bioguideId>C000984</bioguideId>
        <fullName>Rep. Cummings, Elijah E. [D-MD-7]</fullName>
        <middleName>E.</middleName>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <lastName>MORAN</lastName>
        <sponsorshipDate>2013-03-21</sponsorshipDate>
        <firstName>JAMES</firstName>
        <identifiers>
          <bioguideId>M000933</bioguideId>
          <lisID>832</lisID>
          <gpoId>8199</gpoId>
        </identifiers>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <bioguideId>M000933</bioguideId>
        <fullName>Rep. Moran, James P. [D-VA-8]</fullName>
        <middleName>P.</middleName>
        <sponsorshipWithdrawnDate />
      </item>
      <item>
        <lastName>NORTON</lastName>
        <sponsorshipDate>2013-03-21</sponsorshipDate>
        <firstName>ELEANOR</firstName>
        <identifiers>
          <gpoId>7871</gpoId>
          <lisID>868</lisID>
          <bioguideId>N000147</bioguideId>
        </identifiers>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <bioguideId>N000147</bioguideId>
        <fullName>Rep. Norton, Eleanor Holmes [D-DC-At Large]</fullName>
        <middleName>HOLMES</middleName>
        <sponsorshipWithdrawnDate />
      </item>
    </cosponsors>
    <updateDate>2016-10-25T16:01:33Z</updateDate>
    <amendments />
    <originChamber>House</originChamber>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Government Operations and Politics</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Business records</name>
          </item>
          <item>
            <name>Consumer affairs</name>
          </item>
          <item>
            <name>Government employee pay, benefits, personnel management</name>
          </item>
          <item>
            <name>Health care costs and insurance</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
          <item>
            <name>Public contracts and procurement</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <policyArea>
      <name>Government Operations and Politics</name>
    </policyArea>
    <congress>113</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>By Mr. LYNCH:H.R. 1367.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3 and Article I, Section 8,Clause 18[Page H1827]</pre>]]></constitutionalAuthorityStatementText>
    <summaries>
      <billSummaries>
        <item>
          <lastSummaryUpdateDate>2013-04-05T20:31:31Z</lastSummaryUpdateDate>
          <name>Introduced in House</name>
          <actionDesc>Introduced in House</actionDesc>
          <text><![CDATA[<p>FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act - Prohibits the Office of Personnel Management (OPM) from entering a contract or approving a health benefits plan with a carrier that is a party to a pharmacy benefit manager (PBM) carrier arrangement to provide or administer prescription drug coverage under the Federal Employees Health Benefits Program (FEHBP) unless the PBM and the carrier comply with the requirements for PBM carrier arrangements set forth by this Act. Directs OPM to terminate a contract or discontinue a plan that fails to comply with such requirements.</p> <p>Prohibits: (1) a PBM under a carrier arrangement from being under common corporate control with a prescription drug manufacturer or a retail pharmacy, and (2) OPM from permitting a carrier under common corporate control with a PBM to earn a profit from such control.</p> <p>Sets forth terms and requirements for PBM carrier arrangements under the FEHBP, including: (1) drug substitution restrictions, (2) PBM reimbursement of carriers, (3) sale by a PBM of utilization and claims data, (4) drug pricing and the basis for reimbursement, (5) PBM provision to plan enrollees of an explanation of benefits statement regarding prescription drugs, (6) nondiscriminatory contracts regarding required participation, (7) OPM access to PBM contract information, and (8) civil monetary penalties for making false statements or claims to the government.</p>]]></text>
          <actionDate>2013-03-21</actionDate>
          <versionCode>00</versionCode>
          <updateDate>2013-03-21T04:00:00Z</updateDate>
        </item>
      </billSummaries>
    </summaries>
    <sponsors>
      <item>
        <fullName>Rep. Lynch, Stephen F. [D-MA-8]</fullName>
        <byRequestType />
        <bioguideId>L000562</bioguideId>
        <firstName>Stephen</firstName>
        <middleName>F.</middleName>
        <identifiers>
          <lisID>1686</lisID>
          <gpoId>7974</gpoId>
          <bioguideId>L000562</bioguideId>
        </identifiers>
        <lastName>Lynch</lastName>
      </item>
    </sponsors>
    <calendarNumbers />
    <laws />
    <introducedDate>2013-03-21</introducedDate>
    <billNumber>1367</billNumber>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>3</houseOfRepresentatives>
      </actionByCounts>
      <actionTypeCounts>
        <billReferrals>1</billReferrals>
        <introducedInHouse>1</introducedInHouse>
        <introducedInTheHouse>1</introducedInTheHouse>
      </actionTypeCounts>
      <item>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <type>IntroReferral</type>
        <actionDate>2013-03-21</actionDate>
        <text>Referred to the House Committee on Oversight and Government Reform.</text>
        <committee>
          <name>Oversight and Government Reform Committee</name>
          <systemCode>hsgo00</systemCode>
        </committee>
        <actionCode>H11100</actionCode>
        <links />
      </item>
      <item>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <type>IntroReferral</type>
        <actionDate>2013-03-21</actionDate>
        <text>Introduced in House</text>
        <committee />
        <actionCode>Intro-H</actionCode>
        <links />
      </item>
      <item>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <type>IntroReferral</type>
        <actionDate>2013-03-21</actionDate>
        <text>Introduced in House</text>
        <committee />
        <actionCode>1000</actionCode>
        <links />
      </item>
    </actions>
    <notes />
    <titles>
      <item>
        <chamberName />
        <titleType>Short Titles as Introduced</titleType>
        <title>FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act</title>
        <chamberCode />
        <parentTitleType />
      </item>
      <item>
        <chamberName />
        <titleType>Official Title as Introduced</titleType>
        <title>To amend chapter 89 of title 5, United States Code, to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefits Program.</title>
        <chamberCode />
        <parentTitleType />
      </item>
      <item>
        <chamberName />
        <titleType>Display Title</titleType>
        <title>FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act</title>
        <chamberCode />
        <parentTitleType />
      </item>
    </titles>
    <recordedVotes />
    <committees>
      <billCommittees>
        <item>
          <subcommittees />
          <name>Oversight and Government Reform Committee</name>
          <type>Standing</type>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2013-03-21T13:04:50Z</date>
            </item>
          </activities>
          <chamber>House</chamber>
          <systemCode>hsgo00</systemCode>
        </item>
      </billCommittees>
    </committees>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

